Cytolytic T lymphocytes recognize an antigen encoded by MAGE-A10 on a human melanoma.
From melanoma patient LB1751, cytolytic T lymphocytes (CTL) were generated that lysed specifically autologous tumor cells. To establish whether these CTL recognized one of the Ags that had previously been defined, a CTL clone was stimulated with cells expressing various MAGE genes. It produced TNF upon stimulation with target cells expressing MAGE-A10. The Ag was found to be nonapeptide GLYDGMEHL (codons 254-262), which is presented by HLA-A2.1. This is the first report on the generation of anti-MAGE CTL by autologous mixed lymphocyte-tumor cell culture (MLTC) from a melanoma patient other than patient MZ2, from whom the first MAGE gene was identified. MAGE genes are expressed in many tumors but not by normal tissues except male germline cells and placenta, which do not express HLA molecules. Therefore, the identification of an antigenic peptide derived from MAGE-A10 adds to the repertoire of tumor-specific shared Ags available for anti-tumoral vaccination trials.
Huang
L Q
LQ
Ludwig Institute for Cancer Research, Brussels Branch, Belgium.
Brasseur
F
F
Serrano
A
A
De Plaen
E
E
van der Bruggen
P
P
Boon
T
T
Van Pel
A
A
D000368:Aged; D017951:Antigen Presentation; D000951:Antigens, Neoplasm / Q000235:genetics* / Q000276:immunology / Q000378:metabolism*; D002999:Clone Cells; D003602:Cytotoxicity, Immunologic; D052138:Genes, Neoplasm / Q000276:immunology; D006801:Humans; D008297:Male; D008545:Melanoma / Q000235:genetics / Q000276:immunology*; D009363:Neoplasm Proteins / Q000235:genetics* / Q000276:immunology* / Q000378:metabolism; D009842:Oligopeptides / Q000276:immunology / Q000378:metabolism; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology* / Q000378:metabolism; D014407:Tumor Cells, Cultured
D000951:Antigens, Neoplasm; C119317:MAGE-A10 antigen; D009363:Neoplasm Proteins; D009842:Oligopeptides